Artemisinin API Market Revenue was valued at USD 1.5 Billion in 2024 and is estimated to reach USD 2.3 Billion by 2033, growing at a CAGR of 5.2% from 2026 to 2033.
The European Artemisinin Active Pharmaceutical Ingredient (API) market is experiencing significant growth, driven by the increasing demand for antimalarial treatments and the region's robust pharmaceutical infrastructure.
In 2024, Europe's artemisinin market was valued at approximately USD 19.56 million, with projections indicating a compound annual growth rate (CAGR) of 18.0% from 2024 to 2031. This growth is primarily fueled by the rising incidence of malaria and the adoption of artemisinin-based combination therapies (ACTs) across the continent.
Germany and France are leading contributors to this market expansion. Germany's artemisinin market was valued at USD 3.87 million in 2024, with an expected CAGR of 18.2% during the forecast period. France's market is projected to grow at a CAGR of 17.2%, reaching USD 1.80 million by 2032. This growth is attributed to these countries' strong pharmaceutical sectors and their commitment to developing innovative antimalarial treatments.
The primary applications of artemisinin APIs in Europe include antimalarial injections and oral tablets. These formulations are essential in treating malaria, particularly in endemic regions and among travelers. The preference for ACTs has further bolstered the demand for artemisinin APIs, as these therapies are considered the gold standard in malaria treatment due to their efficacy and reduced risk of resistance.
Key players in the European artemisinin API market include Sanofi, KPC Pharmaceuticals, and Guangxi xiancaotang, among others. These companies are focusing on enhancing production capabilities and forming strategic collaborations to meet the growing demand. For instance, Sanofi has been instrumental in developing artemisinin-based treatments, leveraging its extensive research and development resources.
The market is also witnessing a shift towards semisynthetic artemisinin production methods. These methods offer advantages such as improved yield and scalability, addressing supply challenges associated with natural extraction from Artemisia annua. This transition is expected to stabilize supply and reduce costs, making treatments more accessible.
In summary, the European artemisinin API market is poised for substantial growth, driven by increasing demand for effective malaria treatments and advancements in production technologies. The region's strong pharmaceutical industry and strategic initiatives by key players are expected to sustain this growth trajectory, ensuring the availability of affordable and effective antimalarial therapies.
Get an In-Depth Research Analysis of the Europe Artemisinin API Market Size And Forecast [2025-2032]
Sanofi
KPC Pharmaceuticals
Kerui nanhai
Guangxi xiancaotang
Guilin Pharmaceutical
Natural Bio-engineering
BIONEXX
CAT KHANH
BEEPZ
Novanat Bioresource
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Europe region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Artemisinin API Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Artemisinin API Market
Natural Sources
Synthetic Production
Semi-Synthetic Pathways
Antimalarial Medications
Combination Therapies
Research and Development
Injectable Formulations
Oral Formulations
Topical Formulations
Pharmaceutical Companies
Research Institutes
Contract Manufacturing Organizations
Direct Sales
Online Retail
Distributors and Wholesalers
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
For More Information or Query, Visit @ Artemisinin API Market Research Analysis
1. Introduction of the Europe Artemisinin API Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Market Size And Trends
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Artemisinin API Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Artemisinin API Market, By Type
6. Europe Artemisinin API Market, By Application
7. Europe Artemisinin API Market, By Geography
Europe
8. Europe Artemisinin API Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Market Size And Trends
Market Size And Trends is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.marketsizeandtrends.com/